Dapagliflozin mitigates cellular stress and inflammation through PI3K/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived β cells
Fatmah R. Alsereidi(Mayo Clinic), Mohamed A. Saleh, Ahmed Hamam(Armed Forces College of Medicine), Mahmoud M. Ramadan(Mansoura University), Tiana Salomon(Mayo Clinic in Florida), Zenith Khashim(Mayo Clinic in Florida), Hezlin Marzook(University of Sharjah), Moustafa M. Madkour(University of Sharjah), Quinn P. Peterson(Mayo Clinic in Arizona), Mahra K. Almansoori(United Arab Emirates University), Ahmed M. Al-Rawi(University of Sharjah)
Cited by 50
Related Papers
Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation
|Pharmaceuticals|2024|101
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
|Journal of Medicinal Chemistry|2022|66
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
|Life Sciences|2022|62